Search

Your search keyword '"Chorostowska-Wynimko, J"' showing total 283 results

Search Constraints

Start Over You searched for: Author "Chorostowska-Wynimko, J" Remove constraint Author: "Chorostowska-Wynimko, J"
283 results on '"Chorostowska-Wynimko, J"'

Search Results

1. Plasma Acute Phase Proteins as Predictors of Chronic Lung Allograft Dysfunction in Lung Transplant Recipients

2. New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency

3. Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease

4. Correction to: Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases

8. Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications

9. Does urinary peptide content differ between COPD patients with and without inherited alpha-1 antitrypsin deficiency?

10. Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases

11. 46O Preliminary results from a phase IA trial of selective FGFR1-3 inhibitor CPL304110 in patients with FGFR-deregulated advanced solid malignancies

14. HSD57 The Actionable Gaps of the Journey of Patients With Lung Cancer

15. Analysing the molecular landscape of squamous cell carcinoma through simultaneous targeted DNA and RNA-based next-generation sequencing

16. The effect of COVID-19 pandemics on the comprehensive laboratory diagnostic of alpha-1 antitrypsin deficiency in Europe - report from the AATD LABNet

17. The effect of alpha-1 antitrypsin (AAT) augmentation therapy on the liver phenotype in individuals with homozygous Pi*Z AAT mutation (genotype Pi*ZZ)

19. Alpha-1 Antitrypsin Deficiency Laboratory Testing-External Quality Assessment Program AATD LABNet 2019-2021

23. EP16.03-014 Simultaneous Detection of FGFR Gene Aberrations in Squamous Non-small Cell Lung Cancer Using Targeted DNA- and RNA-based NGS

27. Real-time PCR quantification of plasma DNA in non-small cell lung cancer patients and healthy controls

29. Neoadjuvant therapy affects tumor growth markers in early stage non-small-cell lung cancer

30. Einfluss der Augmentationstherapie mit Alpha1-Antitrypsin auf den Leberphänotyp von Individuen mit klassischem Alpha1-Antitrypsin-Mangel (Genotyp Pi*ZZ)

31. P35.05 The Monitoring of Mutated EGFR Levels in Liquid Biopsy from Patients on EGFR-TKIs – Early Detection of NSCLC Progression

32. P09.18 COVID-19 Outcomes in Patients With Thoracic Malignancies According to Gender and Ethnicity (TERAVOLT)

33. P35.08 RNA-Based Gene Alteration and Expression Analysis in Sq-NSCLC with known FGFR1 Amplification and Protein Expression Status

36. European hospital adherence to GOLD recommendations for chronic obstructive pulmonary disease (COPD) exacerbation admissions

37. Populations-basierte Erfassung des Leberphänotyps bei Alpha1-Antitrypsinmangel

38. Leberphänotyp bei Erwachsenen mit compound-heterozygotem Alpha1-Antitrypsin-Mangel (Genotyp Pi*SZ)

39. Die Augmentation mit Alpha1-Antitrypsin assoziiert bei Patienten mit klassischem Alpha1-Antitrypsin-Mangel (Pi*ZZ-Genotyp) mit besseren Leber-Parametern

40. The European Alpha-1 Research Collaboration (EARCO): a new ERS Clinical Research Collaboration to promote research in alpha-1 antitrypsin deficiency

41. P2.11-20 Lung EpiCheck TM - Results of the Training and Test Sets of a Methylation-Based Blood Test for Early Detection of Lung Cancer

44. Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone

49. Influence of Echinacea purpurea intake during pregnancy on fetal growth and tissue angiogenic activity

Catalog

Books, media, physical & digital resources